A biotech startup gives Merck its next shot at treating Alzheimer’s

Alnylam drug succeeds in key heart disease study, boosting company

Merck terminates Lynparza trial in colorectal cancer.

Sanofi, GSK say dual-acting vaccine prevents COVID-19 from omicron in large trial

Alnylam follows rivals with new study results for kidney disease drug

‘Dramatic’ study results for AstraZeneca, Daiichi drug suggest new way to treat breast cancer

Scientists home in on cause of Duchenne gene therapy side effect

Bristol Myers’ Opdivo comes up short in bladder cancer trial.

Lilly wins FDA approval for new kind of diabetes drug.